Clinical Trial Update: Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate

View source ↗

Summary

The trial update compares creatinine clearance calculations for estimating GFR in patients receiving high-dose methotrexate, in the context of CNS lymphoma, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Systemic Lymphoma with Cns Involvement

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: CNS Lymphoma, CNS Involvement of Systemic Lymphoma | Status: COMPLETED